论文部分内容阅读
目的分析研讨美托洛尔片在心衰疾病中的临床应用状况。方法病例入选方式为随机抽签法,从我院2014年3月至2016年2月期间收治的心衰疾病者中,抽取40例纳入到讨论中,此研究为前瞻性研究,40例患者按入院方式分20例对照组(常规治疗)和20例研究组(美托洛尔片治疗),把两组治疗后状况进行对比研讨。结果对比两组患者治疗前脑利钠肽指数,组间数据无统计学意义(P>0.05);对比两组患者治疗7天、15天、30天、90天时,患者脑利钠肽指数状况,研究组比对照组低,组间数据有统计学意义(P<0.05)。对比患者治疗后LVEDD、LVESD、LVEF等指数,研究组比对照组优,组间数据有统计学意义(P<0.05)。结论临床可采用美托洛尔片治疗心衰疾病,疗效突出,可显著降低脑利钠肽,其临床价值较大。
Objective To study the clinical application of metoprolol tablets in heart failure. Methods The method of random selection was randomly selected from 40 cases of heart failure patients admitted from March 2014 to February 2016 in our hospital. The study was a prospective study and 40 patients were admitted to hospital Methods 20 cases of control group (conventional treatment) and 20 cases of study group (metoprolol tablets treatment), the two groups were compared after treatment. Results Comparing the two groups of patients before treatment of brain natriuretic peptide index, the data between the two groups was not statistically significant (P> 0.05); compared two groups of patients treated 7 days, 15 days, 30 days, 90 days, patients with brain natriuretic peptide index status , The study group than the control group, the data between the groups was statistically significant (P <0.05). The LVEDD, LVESD, LVEF and other indices were compared between the two groups. The study group was superior to the control group with statistical significance (P <0.05). Conclusion Metoprolol tablets can be used clinically to treat heart failure, and its curative effect is outstanding. It can significantly reduce brain natriuretic peptide and its clinical value is great.